skip to main content

A perspective on multi-target drug discovery and design for complex diseases

Ramsay, Rona R. ; Popovic-Nikolic, Marija R. ; Nikolic, Katarina ; Uliassi, Elisa ; Bolognesi, Maria Laura

Clinical and translational medicine, 2018-01, Vol.7 (1), p.1-14 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
  • Título:
    A perspective on multi-target drug discovery and design for complex diseases
  • Autor: Ramsay, Rona R. ; Popovic-Nikolic, Marija R. ; Nikolic, Katarina ; Uliassi, Elisa ; Bolognesi, Maria Laura
  • Assuntos: Biological assays ; Cancer ; Cheminformatics ; Medicine ; Medicine & Public Health ; Multi-target drugs ; Neurodegeneration ; Perspective ; Virtual screening
  • É parte de: Clinical and translational medicine, 2018-01, Vol.7 (1), p.1-14
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: Diseases of infection, of neurodegeneration (such as Alzheimer’s and Parkinson’s diseases), and of malignancy (cancers) have complex and varied causative factors. Modern drug discovery has the power to identify potential modulators for multiple targets from millions of compounds. Computational approaches allow the determination of the association of each compound with its target before chemical synthesis and biological testing is done. These approaches depend on the prior identification of clinically and biologically validated targets. This Perspective will focus on the molecular and computational approaches that underpin drug design by medicinal chemists to promote understanding and collaboration with clinical scientists.
  • Editor: Berlin/Heidelberg: Springer Berlin Heidelberg
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.